Radiation Therapy Computed Tomography Solution Boosts Imaging Accuracy

By MedImaging International staff writers
Posted on 07 May 2024

Image: Revolution RT is the latest addition to the company’s Revolution family of CT scanners (Photo courtesy of GE HealthCare)

One of the most significant challenges in oncology care is disease complexity in terms of the variety of cancer types and the individualized presentation of each patient. This complexity necessitates a personalized approach to diagnosis and treatment. Additionally, effective treatment often requires collaboration across multiple disciplines and experts, each specializing in different organs and systems, which can lead to delays in diagnosis and treatment. As the number of patients requiring radiation therapy (RT) increases worldwide, healthcare providers need a CT simulator that not only offers precision simulation but also simplifies the workflow, thereby accelerating patient care. Now, a groundbreaking innovation utilizes artificial intelligence (AI) to streamline the complex radiation therapy workflow, facilitating more personalized and timely care throughout the cancer treatment process.

GE HealthCare (Chicago, IL, USA) has introduced the Revolution RT, a novel radiation therapy computed tomography (CT) system that incorporates advanced hardware and software to enhance imaging accuracy while simplifying the simulation workflow. This aims to provide a more personalized and fluid oncology care pathway for both clinicians and patients. The Revolution RT is built on a wide-bore CT platform, which is integrated with high-performance capabilities for radiation therapy simulation, diagnostics, and interventions. This design allows for the accommodation of a broader range of patients and establishes a more streamlined standard of care. The system features precise radiotherapy simulation which significantly improves imaging accuracy, enhances workflow efficiency, and incorporates deep learning technology to achieve precise imaging of patients.

“At GE HealthCare, we are committed to advancing the frontiers of oncology treatment through AI-driven technologies that transform and optimize the care continuum,” said Dr. Taha Kass-Hout, chief technology and science officer of GE HealthCare. “By integrating these capabilities into our systems, we create a precise, more connected, and efficient care environment that accelerates the delivery of personalized care, with the goal of enabling better patient outcomes. This comprehensive approach empowers clinicians around the globe to tackle the most challenging disease states with precision and efficiency.”